PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

Event features discussions about health care industry trends, best practices and innovations

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies October 18, 2024 Evaluating the...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Help your members take their health to the next level KeepWell™ offers a personalized and effective path to wellness, supporting members with obesity, diabetes, hypertension and high cholesterol....

Discover next-gen pharmacy solutions We deliver innovative pharmacy benefit management and a differentiated experience that puts customer and member needs first Breadcrumb Home Who we are About us...

publications High-Cost Therapy Profile: April 2025 Deramiocel Intravenous (IV) | Nippon Shinyaku Co., Ltd./Capricor Therapeutics, Inc. Cardiovascular/Musculoskeletal April 15, 2025 Proposed...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Drug Approvals September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and...

Event features Prime experts

2024 AMCP Annual Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Annual Meeting. Click on the poster image to view the full-size version. Save: Making medications more...

Help your members on high-cost clinical drugs Our deep expertise and holistic view of patient care help you manage the most complex conditions and expensive specialty drugs across both pharmacy...

Annual meeting will feature industry research posters and educational sessions

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

The SIU promotes safety to prevent fraud, waste and abuse schemes

Oncology Insights Oncology Case Management and Navigation: How do they differ? October 14, 2024 Caring for and treating a patient with cancer is complex. Many patients struggle to coordinate...

In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...

Support members with autoimmune diseases We help members navigate their autoimmune diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...

Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...

2024 AMCP Nexus Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus event. Click on the poster image to view the full-size version. Save: Making medications more...

Constant communication across the supply chain limits disruption when a drug is unavailable

publications High Cost Therapy Profile: December 2024 Remestemcel-L Intravenous (IV) Mesoblast Limited December 11, 2024 Autoimmune/immunology Proposed indications Treatment of...

Support members with rare diseases We help members navigate rare diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management Rare diseases Learn more...

See our history Our teams have poured energy, integrity and compassion into transforming pharmacy solutions, turning barriers into breakthroughs. Breadcrumb Home Who we are Our history Tab 1 2021 –...

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

publications Trending Topics & Drug Approvals: May 2025 Your source for the latest drug information highlights June 4, 2025 Trending Topics Hot topics The United States (U.S.) Food and Drug...

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 High Cost Therapy Profile Oncology Imetelstat Intravenous (IV) Geron Proposed...

publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...

See our award-winning people & work Prime delivers unmatched care, groundbreaking research and industry-leading programs and services for health plans, employers and members. Breadcrumb Home Who we...

Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...

Tap into predictive analytics Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and prescriptive analytics....

Get support from the specialists in specialty We provide end-to-end support for patients taking specialty meds, helping them navigate the care journey. Breadcrumb Home Pharmacy Specialty Pharmacy...

Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab August 15, 2024 High Cost Therapy Profile Oncology Linvoseltamab, intravenous (IV) Regeneron...

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Comprehensive PDL services With 40+ years of Medicaid pharmacy experience supporting over half the nation’s programs, we help states manage high drug costs and ensure members get the meds they...